3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
18
Gastrointestinal
8
Lymphoid
7
Other hematologic neoplasm
6
Genitourinary
6
Tumor-Agnostic
5
Thoracic
5
Gynecologic
3
Other
2
Head & Neck
2
Dermatologic
2
CNS
2
Plasma cell
1
Myeloid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
1
Cytopenia
1
Interventions
Cyclophosphamide
11
fludarabine phosphate
8
fludarabine
8
apixaban
7
Mycophenolic Acid
6
Melphalan
6
Busulfan
6
Whole-Body Irradiation
4
Tacrolimus
4
Rivaroxaban
4
Filgrastim
4
Biopsy
4
thymoglobulin
3
X-Rays
3
Specimen Handling
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Hematopoietic Stem Cell Transplantation
3
Granulocyte Colony-Stimulating Factor
3
Enoxaparin
3
Bone Marrow Transplantation
3
Azacitidine
3
venetoclax
2
pegylated granulocyte colony-stimulating factor
2
olaparib
2
Tretinoin
2
Stem Cell Transplantation
2
Mesna
2
Injections
2
Heparin, Low-Molecular-Weight
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Exercise
×
Classical hematology
×
Clear all
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled